デフォルト表紙
市場調査レポート
商品コード
1387345

静注液(IV溶液)市場レポート:2030年までの動向、予測、競合分析

Intravenous Solution Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

静注液(IV溶液)市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

静注液(IV溶液)の動向と予測

世界の静注液市場は、2024年から2030年までのCAGRが8.1%で、2030年までに推定233億米ドルに達すると予想されます。この市場の主な促進要因は、消化器疾患、神経疾患、がんなどの疾病の罹患率の上昇、クリニック、病院、専門ケアユニットなどの医療施設の急速な成長、高度医療技術の成長です。静注液の世界市場の将来は、完全非経口栄養と末梢静脈非経口栄養の市場にビジネスチャンスがあり、有望視されています。

静注液市場の洞察

Lucintelは、単回投与アミノ酸は通常の消化手段では十分な食事や吸収ができない患者に完全な栄養サポートを提供するため、予測期間中も最大セグメントであり続けると予測しています。

欧州は、主要企業のプレゼンスが高く、薬剤の入手が容易で、医療インフラが確立されているため、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界の静注液市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の静注液市場動向(2018-2023)と予測(2024-2030)
  • 製品別の世界の静注液市場
    • 完全非経口栄養
    • 末梢静脈非経口栄養
  • 栄養素別の世界の静注液市場
    • 炭水化物
    • ビタミンとミネラル
    • 単回投与アミノ酸
    • 非経口脂質エマルジョン
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の静注液市場
  • 北米の静注液市場
  • 欧州の静注液市場
  • アジア太平洋の静注液市場
  • その他地域の静注液市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の静注液市場の成長機会
    • 栄養素別の世界の静注液市場の成長機会
    • 地域別の世界の静注液市場の成長機会
  • 世界の静注液市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の静注液市場の生産能力拡大
    • 世界の静注液市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Pfizer
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Vifor Pharma Management
  • Grifols
  • Henry Schein
  • Soxa Formulations & Research
  • B. Braun Melsungen
  • Baxter International
  • Fresenius Kabi
目次

Intravenous Solution Trends and Forecast

The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets. The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

A more than 150-page report is developed to help in your business decisions.

Intravenous Solution by Segment

The study includes a forecast for the global intravenous solution by product, nutrients, and region.

Intravenous Solution Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

Intravenous Solution Market by Nutrients [Shipment Analysis by Value from 2018 to 2030]:

  • Carbohydrates
  • Vitamins & Minerals
  • Single Dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others

Intravenous Solution Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Intravenous Solution Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intravenous solution companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intravenous solution companies profiled in this report include-

  • Pfizer
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Vifor Pharma Management
  • Grifols
  • Henry Schein
  • Soxa Formulations & Research
  • B. Braun Melsungen
  • Baxter International
  • Fresenius Kabi

Intravenous Solution Market Insights

Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Features of the Global Intravenous Solution Market

Market Size Estimates: Intravenous solution market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Intravenous solution market size by product, nutrients, and region in terms of value ($B).

Regional Analysis: Intravenous solution market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, nutrients, and regions for the intravenous solution market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intravenous solution market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the intravenous solution market size?

Answer: The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030.

Q2. What is the growth forecast for intravenous solution market?

Answer: The global intravenous solution market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the intravenous solution market?

Answer: The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

Q4. What are the major segments for intravenous solution market?

Answer: The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets.

Q5. Who are the key intravenous solution market companies?

Answer: Some of the key intravenous solution companies are as follows:

  • Pfizer
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Vifor Pharma Management
  • Grifols
  • Henry Schein
  • Soxa Formulations & Research
  • B. Braun Melsungen
  • Baxter International
  • Fresenius Kabi

Q6. Which intravenous solution market segment will be the largest in future?

Answer: Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Q7. In intravenous solution market, which region is expected to be the largest in next 5 years?

Answer: Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the intravenous solution market by product (total parenteral nutrition and peripheral parenteral nutrition), nutrients (carbohydrates, vitamins & minerals, single dose amino acids, parenteral lipid emulsion, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Intravenous Solution Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Intravenous Solution Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Intravenous Solution Market by Product
    • 3.3.1: Total Parenteral Nutrition
    • 3.3.2: Peripheral Parenteral Nutrition
  • 3.4: Global Intravenous Solution Market by Nutrients
    • 3.4.1: Carbohydrates
    • 3.4.2: Vitamins & Minerals
    • 3.4.3: Single Dose Amino Acids
    • 3.4.4: Parenteral Lipid Emulsion
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Intravenous Solution Market by Region
  • 4.2: North American Intravenous Solution Market
    • 4.2.2: North American Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
  • 4.3: European Intravenous Solution Market
    • 4.3.1: European Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
    • 4.3.2: European Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
  • 4.4: APAC Intravenous Solution Market
    • 4.4.1: APAC Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
    • 4.4.2: APAC Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
  • 4.5: ROW Intravenous Solution Market
    • 4.5.1: ROW Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
    • 4.5.2: ROW Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Intravenous Solution Market by Product
    • 6.1.2: Growth Opportunities for the Global Intravenous Solution Market by Nutrients
    • 6.1.3: Growth Opportunities for the Global Intravenous Solution Market by Region
  • 6.2: Emerging Trends in the Global Intravenous Solution Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Intravenous Solution Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intravenous Solution Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Otsuka Pharmaceutical
  • 7.3: Sichuan Kelun Pharmaceutical
  • 7.4: Vifor Pharma Management
  • 7.5: Grifols
  • 7.6: Henry Schein
  • 7.7: Soxa Formulations & Research
  • 7.8: B. Braun Melsungen
  • 7.9: Baxter International
  • 7.10: Fresenius Kabi